1. Patients with a diagnosis of head/neck, lung, pancreatic cancer, or metastatic cancer from any solid tumor

2. Planned, ongoing, or recently treated patient (within the past 30 days) with chemotherapy, immunotherapy, and/or intravenous targeted biologic therapy

3. No previous use of appetite stimulants

4. All patients must sign study specific informed consent prior to being included in the study

5. No contraindication to appetite stimulants

Nutrition and Pharmacological Algorithm for Oncology Patients Study

What this study is about